Companies / BOC Sciences / Remtolumab
BOC Sciences

Remtolumab | BOC Sciences

Remtolumab is a dual variable domain immunoglobulin targeting human TNF and IL-17A that can be used in the research of rheumatoid arthritis (RA) treatment.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.